The global airlift bioreactor market is expected to grow at a significant CAGR of 10.5% during the forecast period. The growth of the market is mainly driven by the rise in the biopharmaceutical industry and the increasing prevalence of various chronic diseases such as cancer, diabetes, heart diseases, and viral illnesses. According to the Reserve Bank of India (RBI), the Indian Pharmaceutical sector contributed nearly 2% to India's GDP. Moreover, the Indian pharmaceutical market export turnover was $24.2 billion in 2020-21. India's domestic pharmaceutical market was $41 billion in 2021, and likely to grow to $65 billion by 2024, and further expected to reach $130 billion by 2030.
Browse the full report description of “Global Airlift Bioreactor Market Size, Share and Trends Analysis Report, By Product (Internal Airlift Loop Bioreactors and External Airlift Loop Bioreactor), By Usage (Single Use Disposable and Reusable), By End-User (Biopharmaceutical Companies and Contract Research Organizations/Contract Development Manufacturing Organizations), Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/airlift-bioreactor-market
The market players are focusing on the adoption of various strategies including mergers and acquisitions, partnerships, new product launches, and collaborations, to stay competitive in the market. For instance. in April 2019, Freeline together with Pall Corp. announced the completion of the first full-scale run in Freeline’s newly commissioned Good Manufacturing Practice(GMP) located in Stevenage UK. The Freeline propriety adeno-associated virus (AAV), manufacturing platforms use Pall’s iCELLis bioreactor, which offers highly efficient production of the AVV in a way that maximizes both quality and yield. The collaboration offers Freeline to take the advantage of the small footprint of the bioreactor of Pall. Moroever, in March 2020, Sartorius launched the BIOSTAT STR generation 3 single-use bioreactor and Biobrain automation platform introducing an innovation that change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production. This robust industrial platform consists of hardware, software, and consumables for single-use process development and commercial biomanufacturing. Biostat STR bioreactors and Flexsafe STR bags range from 12.5L to 2000L in the working volume.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered-
o By Type
o By Usage
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Sartorius AG, Lonza AG, and Knik Technology, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Airlift Bioreactor Market Report by Segment
By Product
By Usage
By End-User
Global Airlift Bioreactor Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/airlift-bioreactor-market